Why it Matters
Medicare agent fees are at the center of Integrity Marketing Group’s renewed lobbying push: the company reported $110,000 in Q3 spending with Horizon Government Affairs as part of an $885,000 effort since 2023.
The insurance distribution giant disclosed new spending with Horizon to influence regulations that could reshape its agent-driven business model.
By the Numbers
- Latest Filing: $110,000 for Q3 2025 with Horizon Government Affairs
- Total Lobbying History: $885,000 across 12 filings since 2023
- Primary Partnership: $810,000 with Horizon across 9 filings
- Lobbying Team: Four lobbyists including Joel C. White and Brett Hamilton Meeks
Broader Context
Medicare Advantage enrollment is at a record high, with more than half of beneficiaries in private plans. Recent congressional hearings and increased scrutiny of marketing and third-party brokers place agent compensation squarely on the policy agenda. The nomination hearings for the CMS Administrator and proposed rule changes for Contract Year 2025 signal potential regulatory shifts.
The Agenda
Integrity’s latest disclosure lists its lobbying targets as “insurance agent and broker fees in Medicare” and CMS Contract Year 2025 rulemaking. Because Integrity depends heavily on independent agent networks, compensation rules would be existential to its distribution model.
Competitive Landscape
Integrity is one of many firms engaging policymakers: AmeriLife Group LLC, major insurers like Elevance Health Inc., trade groups such as America’s Health Insurance Plans, and platforms like eHealth Inc. have invested heavily on related Medicare and enrollment issues.
Between the Lines
Bipartisan criticism is rising. Lawmakers have accused Medicare Advantage plans and marketing middlemen of problematic practices — including broker payouts that some members of Congress have spotlighted. Legislative proposals such as the Independent BROKERS TIME Act (S.2625) and investigations led by Senator Ron Wyden increase the odds of policy changes this Congress.
The Bottom Line
Integrity’s sustained spending shows how high the stakes are for insurance distributors as Medicare Advantage faces tougher oversight and potential limits on agent compensation. Expect lobbying and legislative maneuvering to continue as CMS and Congress consider new rules.
For broader coverage, see our pieces on Medicare Advantage and healthcare lobbying. For authoritative resources, read CMS guidance on Medicare and rulemaking at CMS.gov and the bill text for S.2625 at Congress.gov.